Position in QGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,225
+$8,931 QoQ
Shares Held
594
+66.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#269
of 336 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $13,571,646 across 27 Diagnostics & Research names. QGEN ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
9,924 | $4,975,496 | |
| 2 | MEDP |
Medpace Holdings, Inc.
|
9,367 | $4,960,669 | |
| 3 | DHR |
Danaher Corp /De/
|
5,136 | $978,305 | |
| 4 | A |
Agilent Technologies, Inc.
|
4,276 | $567,981 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
932 | $490,642 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,443 | $404,040 | |
| 7 | ILMN |
Illumina, Inc.
|
1,331 | $234,029 | |
| 8 | WAT |
Waters Corp /De/
|
533 | $199,896 |
All Filings in QGEN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,225 | 594 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,294 | 357 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $63,182 | 1,405 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $57,771 | 1,293 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $54,548 | 1,135 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,405 | 35 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||